Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
W. P. Carey Inc is a reit-diversified business based in the US. WPCarey shares (WPC) are listed on the NYSE and all prices are listed in US Dollars. WPCarey employs 188 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$76.22|
|52-week range||$58.40 - $82.37|
|50-day moving average||$77.98|
|200-day moving average||$75.27|
|Wall St. target price||$85.43|
|Dividend yield||$4.188 (5.5%)|
|Earnings per share (TTM)||$2.56|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-17)||-0.03%|
|1 month (2021-08-24)||-0.54%|
|3 months (2021-06-24)||-1.35%|
|6 months (2021-03-24)||10.29%|
|1 year (2020-09-24)||19.67%|
|2 years (2019-09-24)||-15.20%|
|3 years (2018-09-24)||17.66%|
|5 years (2016-09-23)||13.64%|
Valuing WPCarey stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of WPCarey's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
WPCarey's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 30x. In other words, WPCarey shares trade at around 30x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
WPCarey's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.1 billion.
The EBITDA is a measure of a WPCarey's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.3 billion|
|Operating margin TTM||49.21%|
|Gross profit TTM||$1.2 billion|
|Return on assets TTM||2.68%|
|Return on equity TTM||6.47%|
|Market capitalisation||$14.4 billion|
TTM: trailing 12 months
There are currently 6.6 million WPCarey shares held short by investors – that's known as WPCarey's "short interest". This figure is 72% up from 3.9 million last month.
There are a few different ways that this level of interest in shorting WPCarey shares can be evaluated.
WPCarey's "short interest ratio" (SIR) is the quantity of WPCarey shares currently shorted divided by the average quantity of WPCarey shares traded daily (recently around 872342.10526316). WPCarey's SIR currently stands at 7.6. In other words for every 100,000 WPCarey shares traded daily on the market, roughly 7600 shares are currently held short.
However WPCarey's short interest can also be evaluated against the total number of WPCarey shares, or, against the total number of tradable WPCarey shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case WPCarey's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 WPCarey shares in existence, roughly 40 shares are currently held short) or 0.0364% of the tradable shares (for every 100,000 tradable WPCarey shares, roughly 36 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against WPCarey.
Find out more about how you can short WPCarey stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like WPCarey.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 23.23
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and WPCarey's overall score of 23.23 (as at 12/31/2018) is excellent – landing it in it in the 17th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like WPCarey is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 8.59/100
WPCarey's environmental score of 8.59 puts it squarely in the 8th percentile of companies rated in the same sector. This could suggest that WPCarey is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 12/100
WPCarey's social score of 12 puts it squarely in the 8th percentile of companies rated in the same sector. This could suggest that WPCarey is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 10.65/100
WPCarey's governance score puts it squarely in the 8th percentile of companies rated in the same sector. That could suggest that WPCarey is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
|Total ESG score||23.23|
|Total ESG percentile||17.46|
|Environmental score percentile||8|
|Social score percentile||8|
|Governance score percentile||8|
Dividend payout ratio: 91.62% of net profits
Recently WPCarey has paid out, on average, around 91.62% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 5.52% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), WPCarey shareholders could enjoy a 5.52% return on their shares, in the form of dividend payments. In WPCarey's case, that would currently equate to about $4.188 per share.
WPCarey's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
WPCarey's most recent dividend payout was on 14 July 2021. The latest dividend was paid out to all shareholders who bought their shares by 28 June 2021 (the "ex-dividend date").
Over the last 12 months, WPCarey's shares have ranged in value from as little as $58.3993 up to $82.37. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while WPCarey's is 0.7489. This would suggest that WPCarey's shares are less volatile than average (for this exchange).
W. P. Carey ranks among the largest net lease REITs with an enterprise value of approximately $18 billion and a diversified portfolio of operationally-critical commercial real estate that includes 1,215 net lease properties covering approximately 142 million square feet as of September 30, 2020. For nearly five decades, the company has invested in high-quality single-tenant industrial, warehouse, office, retail and self-storage properties subject to long-term net leases with built-in rent escalators. Its portfolio is located primarily in the U. S. and Northern and Western Europe and is well-diversified by tenant, property type, geographic location and tenant industry.
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Sep. 20, 2021
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.